Stock Track | 10x Genomics Soars 9.75% in Pre-market as Canaccord Genuity Maintains Buy Rating

Stock Track

May 12, 2025

Shares of 10x Genomics, Inc. (TXG) are soaring 9.75% in pre-market trading on Monday, showcasing significant investor optimism at the start of the week. The stock's impressive surge comes as the company receives a vote of confidence from a major financial institution.

The catalyst for this upward movement appears to be Canaccord Genuity's decision to maintain its Buy rating on 10x Genomics. While specific details of the analyst report are not provided, the continuation of a positive outlook from a respected financial firm often signals strong fundamentals and growth potential, which can drive investor enthusiasm.

10x Genomics, a life science technology company, is known for its innovative genomics solutions. The maintained Buy rating suggests that Canaccord Genuity sees continued value in the company's products and market position. As the biotechnology and genomics sectors continue to evolve rapidly, positive analyst sentiments can significantly influence investor perceptions and stock performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1159850199"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1159850199\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1159850199?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-12 21:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159850199","market":"nz","top_or_hot":-1,"title":"Stock Track | 10x Genomics Soars 9.75% in Pre-market as Canaccord Genuity Maintains Buy Rating","media":"Stock Track","content":"<p>Shares of 10x Genomics, Inc. (TXG) are soaring 9.75% in pre-market trading on Monday, showcasing significant investor optimism at the start of the week. The stock's impressive surge comes as the company receives a vote of confidence from a major financial institution.</p>\n\n<p>The catalyst for this upward movement appears to be Canaccord Genuity's decision to maintain its Buy rating on 10x Genomics. While specific details of the analyst report are not provided, the continuation of a positive outlook from a respected financial firm often signals strong fundamentals and growth potential, which can drive investor enthusiasm.</p>\n\n<p>10x Genomics, a life science technology company, is known for its innovative genomics solutions. The maintained Buy rating suggests that Canaccord Genuity sees continued value in the company's products and market position. As the biotechnology and genomics sectors continue to evolve rapidly, positive analyst sentiments can significantly influence investor perceptions and stock performance.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | 10x Genomics Soars 9.75% in Pre-market as Canaccord Genuity Maintains Buy Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | 10x Genomics Soars 9.75% in Pre-market as Canaccord Genuity Maintains Buy Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-12 21:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of 10x Genomics, Inc. (TXG) are soaring 9.75% in pre-market trading on Monday, showcasing significant investor optimism at the start of the week. The stock's impressive surge comes as the company receives a vote of confidence from a major financial institution.</p>\n\n<p>The catalyst for this upward movement appears to be Canaccord Genuity's decision to maintain its Buy rating on 10x Genomics. While specific details of the analyst report are not provided, the continuation of a positive outlook from a respected financial firm often signals strong fundamentals and growth potential, which can drive investor enthusiasm.</p>\n\n<p>10x Genomics, a life science technology company, is known for its innovative genomics solutions. The maintained Buy rating suggests that Canaccord Genuity sees continued value in the company's products and market position. As the biotechnology and genomics sectors continue to evolve rapidly, positive analyst sentiments can significantly influence investor perceptions and stock performance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TXG","symbol_name":"10x Genomics, Inc.","start_time":0,"source_url":"","article_id":"1159850199","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159850199","pubTimestamp":1747057264,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of 10x Genomics, Inc.  are soaring 9.75% in pre-market trading on Monday, showcasing significant investor optimism at the start of the week. The stock's impressive surge comes as the company receives a vote of confidence from a major financial institution.The catalyst for this upward movement appears to be Canaccord Genuity's decision to maintain its Buy rating on 10x Genomics. While specific details of the analyst report are not provided, the continuation of a positive outlook from a res","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TXG":"10x Genomics, Inc."},"translate_title":"Canaccord Genuity维持买入评级，股票赛道10x Genomics盘前飙升9.75%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":1},"content_text":"Shares of 10x Genomics, Inc. (TXG) are soaring 9.75% in pre-market trading on Monday, showcasing significant investor optimism at the start of the week. The stock's impressive surge comes as the company receives a vote of confidence from a major financial institution.\nThe catalyst for this upward movement appears to be Canaccord Genuity's decision to maintain its Buy rating on 10x Genomics. While specific details of the analyst report are not provided, the continuation of a positive outlook from a respected financial firm often signals strong fundamentals and growth potential, which can drive investor enthusiasm.\n10x Genomics, a life science technology company, is known for its innovative genomics solutions. The maintained Buy rating suggests that Canaccord Genuity sees continued value in the company's products and market position. As the biotechnology and genomics sectors continue to evolve rapidly, positive analyst sentiments can significantly influence investor perceptions and stock performance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}